These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 6246007

  • 21. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide.
    Mueller-Lantzsch N, Yamamoto N.
    J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267
    [Abstract] [Full Text] [Related]

  • 22. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
    Klein G, Zeuthen J, Ber R, Ernberg I.
    J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
    [Abstract] [Full Text] [Related]

  • 23. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma.
    Okano M, Aya T, Mizuno F, Takada K, Osato T.
    Tohoku J Exp Med; 1993 Jun; 170(2):71-9. PubMed ID: 8266328
    [Abstract] [Full Text] [Related]

  • 24. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
    Vestergaard BF, Hesse J, Norrild B, Klein G.
    Int J Cancer; 1978 Mar 15; 21(3):323-8. PubMed ID: 75856
    [Abstract] [Full Text] [Related]

  • 25. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
    Ernberg I, Kallin B, Dillner J, Falk K, Ehlin-Henriksson B, Hammarskjöld ML, Klein G.
    Int J Cancer; 1986 Nov 15; 38(5):729-37. PubMed ID: 3021635
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Differential inducibility of Epstein-Barr virus in cloned, non-producer Raji cells.
    Bister K, Yamamoto N, zur Hausen H.
    Int J Cancer; 1979 Jun 15; 23(6):818-25. PubMed ID: 89100
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus.
    Klein G, Falk L, Falk K.
    Intervirology; 1978 Jun 15; 10(3):153-64. PubMed ID: 210135
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin.
    Shapiro IM, Luka J, Andersson-Anvret M, Klein G.
    Intervirology; 1979 Jun 15; 12(1):19-25. PubMed ID: 227812
    [Abstract] [Full Text] [Related]

  • 36. Abortive expression of the Epstein-Barr virus (EBV) cycle in a variety of EBV DNA-containing cell lines, as reflected by nucleic acid hybridization in situ.
    Moar MH, Klein G.
    Int J Cancer; 1979 Nov 15; 24(5):679-87. PubMed ID: 93584
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate].
    Furukawa M, Kato C, Kamide M, Umeda R.
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Feb 15; 92(2):189-93. PubMed ID: 2545850
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.